5.44 - 5.64
4.95 - 8.28
2.1K / 2.4K (Avg.)
-272.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
11.77%
Revenue growth 1.25-1.5x HUH1V.HE's 9.30%. Bruce Berkowitz would check if differentiation or pricing power justifies outperformance.
7.65%
Gross profit growth 1.25-1.5x HUH1V.HE's 5.41%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
-0.91%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-0.91%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-3.88%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-3.23%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-3.23%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.24%
Share reduction while HUH1V.HE is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.68%
Reduced diluted shares while HUH1V.HE is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-97.08%
Negative OCF growth while HUH1V.HE is at 6.73%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-429.73%
Negative FCF growth while HUH1V.HE is at 57.39%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
14.89%
10Y revenue/share CAGR under 50% of HUH1V.HE's 80.52%. Michael Burry would suspect a lasting competitive disadvantage.
50.41%
5Y revenue/share CAGR similar to HUH1V.HE's 48.10%. Walter Schloss might see both companies benefiting from the same mid-term trends.
39.55%
3Y revenue/share CAGR 1.25-1.5x HUH1V.HE's 32.27%. Bruce Berkowitz might see better product or regional expansions than the competitor.
107.78%
Positive long-term OCF/share growth while HUH1V.HE is negative. John Neff would see a structural advantage in sustained cash generation.
-92.02%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-91.00%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-29.93%
Negative 10Y net income/share CAGR while HUH1V.HE is at 47.09%. Joel Greenblatt sees a major red flag in long-term profit erosion.
233.33%
5Y net income/share CAGR above 1.5x HUH1V.HE's 11.16%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
200.00%
3Y net income/share CAGR above 1.5x HUH1V.HE's 14.05%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
99.92%
10Y equity/share CAGR in line with HUH1V.HE's 107.29%. Walter Schloss might see both benefiting from stable profitability and moderate payout ratios over the decade.
75.89%
5Y equity/share CAGR 1.25-1.5x HUH1V.HE's 56.93%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
39.83%
3Y equity/share CAGR similar to HUH1V.HE's 38.08%. Walter Schloss sees both having parallel profitability or reinvestment over 3 years.
No Data
No Data available this quarter, please select a different quarter.
155.52%
Stable or rising mid-term dividends while HUH1V.HE is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
56.16%
Our short-term dividend growth is positive while HUH1V.HE cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-100.00%
Firm’s AR is declining while HUH1V.HE shows 7.04%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
8.25%
Inventory growth well above HUH1V.HE's 10.45%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.18%
Negative asset growth while HUH1V.HE invests at 7.99%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
2.95%
50-75% of HUH1V.HE's 5.30%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-1.37%
We’re deleveraging while HUH1V.HE stands at 10.90%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
10.20%
SG&A growth well above HUH1V.HE's 7.05%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.